The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflamm…
Listeners of Neurology® Podcast that love the show mention: neurology podcast, neurologists, trainees, inflammation, residency, clinicians, always relevant, editor, date, clearly, commute, quality, resource, practical, easy, conversations, learning, excellent, informative, content.
The Neurology Podcast is an excellent resource for healthcare professionals, particularly those in the field of neurology. Hosted by Editor Stacey Clardy, this podcast provides informative and organized discussions on a variety of topics relevant to residency and clinical practice. One of the best aspects of this podcast is Clardy's ability to keep the interviewers on topic while maintaining a sense of humor. This makes the conversations engaging and enjoyable to listen to.
The content of this podcast is top-notch and easy to follow, making it a great educational resource for those in residency or seeking to stay up-to-date with developments in neurology. The interviews are formatted as conversations that anyone can follow, regardless of their level of training. The podcast covers recent discoveries from the research community and provides clear answers about the research's clinical relevance. Additionally, the professional quality of the recording is superior to many other podcasts, making it easy for listeners to understand and enjoy.
One potential downside of this podcast is that it may not be as accessible or beneficial for non-medical listeners. While it provides valuable information for healthcare professionals, individuals without a background in neurology may find some episodes technical or challenging to comprehend fully.
In conclusion, The Neurology Podcast is an excellent educational resource that provides valuable insights into various topics in neurology. Its informative and organized format, along with engaging conversations and high-quality recordings, make it a standout among medical podcasts. Whether you are a resident, nurse, or neurologist looking to stay up-to-date on the latest research and clinical practices, this podcast is highly recommended.
Dr. Dan Ackerman talks with Dr. Reza Bavarsad Shahripour about the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Dr. Shuvro Roy talks with Dr. Amanda L. Piquet about the efficacy and safety of miv-cel in patients with stiff person syndrome. Read more about this abstract on the AAN website. Disclosures can be found at Neurology.org.
In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Disclosures can be found at Neurology.org.
In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Disclosures can be found at Neurology.org.
The June 2026 Recall highlights four previously posted episodes on parkinsonian disorders. The episode begins with Dr. Valtteri Kaasinen discussing the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. The discussion continues with Dr. YuHong Fu, who addresses the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. The third episode features Dr. Daniel Weintraub discussing clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. The episode concludes with Prof. Franziska Hopfner discussing the frequency and disease trajectory of MSA patients who do not experience dysautonomia, compared with those who have autonomic involvement. Podcast links: Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years Dementia with Lewy Bodies and Parkinson Disease Dementia Clinical Approach to Dementia Risk in Patients with Parkinson Disease Multiple System Atrophy Without Dysautonomia Article links: Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years Dementia with Lewy bodies and Parkinson Disease Dementia — The Same or Different and is it Important? Long-Term Dementia Risk in Parkinson Disease Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study Disclosures can be found at Neurology.org.
Dr. Gregg Day talks with Drs. Sonia Vallabh and Eric Minikel about scientific insights and the future of prion disease treatment, highlighting the importance of early diagnosis, personalized medicine, and hope for affected families. Learn about the clinical trial. Learn more about the Prion Alliance. Disclosures can be found at Neurology.org.
In the second episode of this series, Dr. Tesha Monteith and Dr. Peter Goadsby continue their conversation on advances in headache medicine, including brain health, migraine as a risk factor for dementia, and future directions in neurology. Disclosures can be found at Neurology.org.
In the first part of this series, Dr. Tesha Monteith talks with Dr. Peter Goadsby about some major themes that emerged from the AAN Annual Meeting regarding headache medicine. Disclosures can be found at Neurology.org.
Dr. Alex Menze talks with Dr. Breton Asken about the long-term impacts of repetitive head impacts in football players, focusing on inflammation, brain microstructure, and cognitive decline. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Kait Nevel about radiation necrosis following radiation therapy, with a closer look at Boswellia serrata supplement findings. Please read the related article mentioned in this episode. Disclosures can be found at Neurology.org.
Dr. Alex Menze talks with Dr. Kathryn C. Fitzgerald about using accelerometry to detect subtle, longitudinal changes in disability in people with multiple sclerosis and how these changes relate to brain atrophy and disability progression. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Katie Krulisky talks with Dr. Cristina Domínguez-González about the complexities of mitochondrial disease, including diagnosis, biomarkers, and recent research on POLG-related disorders. Read the related article in Neurology® Genetics. Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Drs. Deborah Hall and Deborah Setter about the current situation for lactating individuals in neurology and the opportunities for improvement in the workplace. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
The May 2026 Recall highlights four in‑depth conversations focused on the clinical approach to monocular vision loss. The episode opens with Dr. Dan Ackerman leading a two-part series with Drs. Valérie Biousse and Nancy J. Newman on the challenges and opportunities in diagnosing CRAO and BRAO. The episode continues with a second, two‑part series in which Dr. Justin Abbatemarco speaks with Drs. Valérie Biousse and Nancy J. Newman about updates in non‑arteritic ischemic optic neuropathy. Podcast links: Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 1 Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 2 Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1 Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2 Related article: Eye Stroke Protocol in the Emergency Department Disclosures can be found at Neurology.org.
Dr. Zohaib Siddiqi talks with Dr. Laurence Poirier about a complex stroke case associated with systemic vasculitis, highlighting diagnostic challenges and management strategies, including the role of endovascular therapy. Read the related Resident & Fellow Section article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Paulus Rommer about the evolving understanding of Epstein-Barr virus (EBV) and its role in multiple sclerosis (MS), including recent research on EBV antibodies as diagnostic markers and potential therapeutic targets. Read the related article in JAMA Neurology. Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Layne Dylla about the trends in head CT use in US emergency departments from 2007 to 2022, highlighting disparities, regional variations, and the potential role of AI in optimizing imaging decisions. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. Alison Christy, the recipient of the 2026 Ted Burns Humanism in Neurology Award, about her inspiring career, innovative approaches to neurology education, and how she fosters compassion and creativity in medicine. Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Walter J. Koroshetz about his journey from a childhood fascination with the brain to leading the NINDS and his enduring commitment to advocacy, scientific rigor, and patient care. Read more about the 2026 AAN President's Award. Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care. Read the related article in The Lancet Neurology. Disclosures can be found at Neurology.org.
As we celebrate the 75th anniversary of Neurology®, Dr. Jeff Ratliff talks with Drs. Steven Galetta and Robert Griggs about the history and evolution of the Letters to the Editor section. Join the conversation by visiting the Letters to the Editor section. Disclosures can be found at Neurology.org.
Dr. H.E. Hinson talks with Dr. Vijay Ramanan about the upcoming Clinical Trials Plenary Session at the AAN Annual Meeting and the landmark studies shaping neurological care. For more information about this event, visit the AAN website. Disclosures can be found at Neurology.org.
Dr. Derek Stitt talks with Dr. Page B. Pennell about antiseizure medication management during pregnancy and postpartum, based on the MONEAD study. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
The April 2026 recall features four previously posted episodes on vascular neurology. The episode begins with Dr. Shyam Prabhakaran discussing the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke. The episode continues with Dr. Seemant Chaturvedi discussing the latest findings from the 2026 International Stroke Conference. In the third episode, Dr. Amrou Sarraj discusses the importance of understanding anesthesia's impact on patient outcomes, the implications for clinical practice, and future research directions in stroke treatment. The episode concludes with Dr. Urs Fischer discussing the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. Podcast links: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke Overview from the 2026 International Stroke Conference General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation Article links: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients With Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial Collaboration on The Optimal Timing of Anticoagulation After Ischaemic Stroke and Atrial Fibrillation Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Lizzy Lawrence about the FDA's shift toward single-trial drug approvals and its implications for neurology, rare diseases, and broader effects on drug approval standards and healthcare access. Read the related article on STAT News. Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Sara Hassani about periprocedural brain health and calls on neurologists to engage in multidisciplinary efforts to improve periprocedural outcomes. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Paul Crane talks with Dr. Hanalise Huff about neurologic and neurocognitive sequelae in pediatric survivors of the 2015 Ebola outbreak in Liberia. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. Kerry Sheets about how hearing aid use affects cognition and the risk of dementia in older adults with hearing impairment. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Jessica Ailani talks with Dr. Richard Lipton about future advancements in headache medicine. Disclosures can be found at Neurology.org.
Dr. Halley Alexander talks with Dr. Abel Sandmann about seizure rates and risk factors in patients with cerebral cavernous malformations (CCMs) during long-term follow-up without CCM intervention. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Jennifer Robblee about the latest consensus on refractory migraine, its definition, and management strategies, including new guidelines for emergency treatment. Read the related article in Cephalalgia. Read the related article in Headache. Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2025. Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the latest findings from the 2026 International Stroke Conference. Read more about the CHOICE-2 trial. Read more about the OCEANIC-STROKE trial. Read more about the FASTEST trial. Disclosures can be found at Neurology.org.
The March 2026 recall showcases four previously posted episodes focused on clinical issues relevant to hospital-based neurologists. The episode opens with Dr. Jennifer E. Fugate discussing PRES, focusing on clinical presentation, diagnostic criteria, neuroimaging findings, and management strategies. The episode continues with Dr. Ava Easton discussing the World Health Organization's technical brief on encephalitis. In the third episode, Dr. Matthew Ryan Woodward discusses the complexities of status epilepticus, from definition through refractory and super-refractory stages. The episode concludes with Dr. Adrian Budhram discussing common challenges neurologists face when interpreting CSF results. Podcast links: Evolving Insights into the Diagnosis, Management, and Outcomes of PRES WHO Launches Technical Brief for Encephalitis Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication CSF Correction Factors for Traumatic Lumbar Puncture in Adults Article links: Posterior Reversible Encephalopathy Syndrome: Evolving Insights in Diagnosis, Management, and Outcomes WHO Launches Technical Brief for Encephalitis Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication Clinical Utility of CSF Correction Factors for Traumatic Lumbar Puncture in Adults Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Shyam Prabhakaran about the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke, highlighting key recommendations, the role of advanced imaging, and the importance of thrombolysis and thrombectomy. Read the related article in the journal Stroke. Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Marjo S. van der Knaap and Romy J. van Voorst about expert consensus recommendations for the diagnosis and management of vanishing white matter and the importance of standardizing care worldwide. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Alex Menze talks with Dr. Divyanshu Dubey about the clinical insights into autoimmune nodopathies, particularly focusing on CASPR1 and CASPR1/CNTN1-complex-IgG. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Halley Alexadner talks with Dr. Alissa M. D'Gama about genetic testing for infantile epilepsies. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Greg Cooper talks with Dr. David G. Coughlin about the role of αSyn-SAAs in diagnosing dementia with Lewy bodies and their relationship with Alzheimer disease biomarkers. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Andrew D. Hershey about the advancements in the treatment of pediatric migraines. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org.
In this special episode, Dr. Roy Strowd talks with Drs. Jeff Ratliff, Tesha Monteith, and Justin Abbatemarco about non-traditional educational formats and how they're reshaping neurology training. Disclosures can be found at Neurology.org.
Dr. Andy Southerland talks with Dr. Dipika Aggarwal as she shares her profound journey as both a physician and a patient. After battling stage four colon cancer, she faced a stroke that changed her life. Disclosures can be found at Neurology.org.
The February 2026 recall features four previously posted episodes on multiple sclerosis. The episode begins with a conversation with Dr. Wallace J. Brownle discussing whether dissemination in time is essential to diagnois relapsing MS. The discussion continues with Dr. Daniel Ontaneda regarding the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. The episode then transitions into a conversation with Dr. Jiwon Oh about BTK inhibitors and recent data on tolebrutinib in multiple sclerosis. The episode concludes with Dr. Sandra Vukusic addressing the differences in disease-modifying therapies for female versus male patients with multiple sclerosis. Podcast link: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS 2024 McDonald Criteria BTK Inhibitors in Multiple Sclerosis Treatment Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Podcast article: Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple Sclerosis Diagnosis of Multiple Sclerosis: 2024 Revisions of the McDonald Criteria Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis Disclosures can be found at Neurology.org.
Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Dr. Stacey Clardy talks with Dr. John Ney about the prevalence, disability burden, and societal impact of neurologic disorders in the U.S. Read the related article in JAMA. Disclosures can be found at Neurology.org.
In the second episode of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the management of non-arteritic ischemic optic neuropathy and its emerging relationship with GLP‑1 medications. Disclosures can be found at Neurology.org.
In part one of this two-part series, Dr. Justin Abbatemarco talks with Drs. Valérie Biousse and Nancy J. Newman about the clinical features and diagnostic tools utilized for non-arteritic ischemic optic neuropathy (NAION). Disclosures can be found at Neurology.org.
Dr. Justin Abbatemarco talks with Dr. Divyanshu Dubey about how antibodies to synaptophysin and GAP43 help explain an autoimmune neuropathy seen in swine abattoir workers and offer new clues for diagnosing and treating related inflammatory neuropathies. Read the related article in ScienceDirect. Disclosures can be found at Neurology.org.
In the second installment of this two-part series, Dr. Stacey Clardy talks with Drs. Ayush Gupta and Kuntal Sen about the spinal cord and optic neuritis, while outlining practical approaches to genetic testing and emphasizing the importance of collaboration with genetic counselors and neurogeneticists. Read the related article in Neurology® Genetics. Disclosures can be found at Neurology.org.
In part one of this two-part series, Dr. Stacey Clardy talks with Drs. Ayush Gupta and Kuntal Sen about the phenotypes commonly seen in CNS inflammatory and demyelinating diseases, and discuss genetic conditions in patients who do not precisely meet classic diagnostic criteria. Read the related article in Neurology® Genetics. Disclosures can be found at Neurology.org.
Dr. Elizabeth Coon talks with Prof. Franziska Hopfner aboutthe frequency and disease trajectory of MSA patients who do not experience dysautonomia, in comparison to those with autonomic involvement. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
© 2020-2026 Ivy Podcast Discovery LLC
